| Autor: |
Lima NA; Wayne State University School of Medicine - Internal Medicine, Detroit, Michigan - EUA., Rocha EA; Universidade Federal do Ceará - Hospital Universitário Walter Cantídio - Programa de Pós-graduação em Ciências Cardiovasculares da Faculdade de Medicina da UFC, Fortaleza, CE - Brasil., Damasceno A; Universidade Eduardo Mondlane - Faculdade de Medicine, Maputo - Moçambique., Costa IP; Universidade Federal do Ceará - Hospital Universitário Walter Cantídio - Programa de Pós-graduação em Ciências Cardiovasculares da Faculdade de Medicina da UFC, Fortaleza, CE - Brasil., Ricardo JRB; Clinica Girassol, Luanda - Angola., Lopes FJ; Hospital Dr. Baptista de Sousa, Mindelo - Cabo Verde., Dias L; Hospital Agostinho Neto, Praia - Cabo Verde., Soares MBDPC; Hospital Dr. Ayres de Menezes, São Tomé - São Tomé e Príncipe., Puroll E; University of Michigan Medicine, Ann Arbor, Michigan - EUA., Eagle KA; University of Michigan Medicine - Frankel Cardiovascular Center, Ann Arbor, Michigan - EUA., Crawford TC; University of Michigan Medicine - Frankel Cardiovascular Center, Ann Arbor, Michigan - EUA. |
| Abstrakt: |
There is a gap between high-income countries and others in terms of access to medical cardiac devices, such as pacemakers and implantable cardioverter defibrillators. Costs are one of the main barriers to the use of cardiac devices in these countries. There are international initiatives that aim to reduce the gap. The reuse of pacemakers has been discussed as a possible alternative to this problem. The concept of reusing pacemakers is not new; however, recent studies have proven to be safe, ethical, and effective for those who need cardiac implantable electronic devices and cannot afford them. Part of the Portuguese-speaking countries, especially in Africa, need an immediate response that benefits their countless patients who suffer from treatable arrhythmias. |
